News

Atai and Recognify's schizophrenia drug fails to meet main goal in trial
Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive ...
YourTango23h
If You Can Still Control These 5 Things In Your 70s, You're A Rare Gem Of A Person
So there you go, the 5 things you can change to be happy. The year 2025 is upon us. Another new year means another ...
Ozzy Osbourne's rare form of Parkinson's sparks questions about lifestyle factors
Black Sabbath frontman Ozzy Osbourne died following his battle with a genetic form of Parkinson's disease, while a brain ...
The Malaysian Reserve19h
Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer’s disease
The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli ...
eLife19h
No effect of additional education on long-term brain structure, a preregistered natural experiment in thousands of individuals
There is no discernible effect of an additional year of education from a policy change on long-term structural neuroimaging measures in a large aging sample (UK Biobank).
CURE9h
Just a Little Off the Top: Taking the First Step in the Cancer Journey
After brain surgery for a malignant tumor, I faced fears, found strength, and embraced living in the moment as I begin ...